Table 3:

Relationship between longitudinal bicarbonate levels and all-cause mortality censoring at KRT initiation (pre-KRT population).

Q SBCaEvents, N (%),Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st82 (22.8)683.41201.52 (1.11, 2.06); P = .0081.58 (1.16, 2.16); P = .0041.46 (1.06, 2); P = .0191.46 (1.06, 2.02); P = .0221.51 (1.07, 2.11); P = .018
2nd70 (20.3)764.7921.16 (0.85, 1.59); P = .3461.16 (0.84, 1.59); P = .3681.17 (0.85, 1.61); P = .3281.17 (0.85, 1.61); P = .3361.18 (0.85, 1.63); P = .334
3rd88 (22.9)853.51031.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th105 (28.5)823.61271.35 (1, 1.82); P = .0511.31 (0.97, 1.77); P = .0811.22 (0.89, 1.66); P = .2141.22 (0.89, 1.67); P = .2221.19 (0.87, 1.63); P = .284
Q SBCaEvents, N (%),Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st82 (22.8)683.41201.52 (1.11, 2.06); P = .0081.58 (1.16, 2.16); P = .0041.46 (1.06, 2); P = .0191.46 (1.06, 2.02); P = .0221.51 (1.07, 2.11); P = .018
2nd70 (20.3)764.7921.16 (0.85, 1.59); P = .3461.16 (0.84, 1.59); P = .3681.17 (0.85, 1.61); P = .3281.17 (0.85, 1.61); P = .3361.18 (0.85, 1.63); P = .334
3rd88 (22.9)853.51031.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th105 (28.5)823.61271.35 (1, 1.82); P = .0511.31 (0.97, 1.77); P = .0811.22 (0.89, 1.66); P = .2141.22 (0.89, 1.67); P = .2221.19 (0.87, 1.63); P = .284

Time-dependent Cox regression model; overall study population N = 1457.

aQuartiles of serum bicarbonate; SBC, BMI, albumin, SGA, K+ and eGFR treated as time-varying covariates.

bHR and 95% CI adjusted sequentially for confounders (sex, age, BMI, SGA, eGFR, K+, comorbidities, primary renal disease).

Table 3:

Relationship between longitudinal bicarbonate levels and all-cause mortality censoring at KRT initiation (pre-KRT population).

Q SBCaEvents, N (%),Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st82 (22.8)683.41201.52 (1.11, 2.06); P = .0081.58 (1.16, 2.16); P = .0041.46 (1.06, 2); P = .0191.46 (1.06, 2.02); P = .0221.51 (1.07, 2.11); P = .018
2nd70 (20.3)764.7921.16 (0.85, 1.59); P = .3461.16 (0.84, 1.59); P = .3681.17 (0.85, 1.61); P = .3281.17 (0.85, 1.61); P = .3361.18 (0.85, 1.63); P = .334
3rd88 (22.9)853.51031.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th105 (28.5)823.61271.35 (1, 1.82); P = .0511.31 (0.97, 1.77); P = .0811.22 (0.89, 1.66); P = .2141.22 (0.89, 1.67); P = .2221.19 (0.87, 1.63); P = .284
Q SBCaEvents, N (%),Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st82 (22.8)683.41201.52 (1.11, 2.06); P = .0081.58 (1.16, 2.16); P = .0041.46 (1.06, 2); P = .0191.46 (1.06, 2.02); P = .0221.51 (1.07, 2.11); P = .018
2nd70 (20.3)764.7921.16 (0.85, 1.59); P = .3461.16 (0.84, 1.59); P = .3681.17 (0.85, 1.61); P = .3281.17 (0.85, 1.61); P = .3361.18 (0.85, 1.63); P = .334
3rd88 (22.9)853.51031.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th105 (28.5)823.61271.35 (1, 1.82); P = .0511.31 (0.97, 1.77); P = .0811.22 (0.89, 1.66); P = .2141.22 (0.89, 1.67); P = .2221.19 (0.87, 1.63); P = .284

Time-dependent Cox regression model; overall study population N = 1457.

aQuartiles of serum bicarbonate; SBC, BMI, albumin, SGA, K+ and eGFR treated as time-varying covariates.

bHR and 95% CI adjusted sequentially for confounders (sex, age, BMI, SGA, eGFR, K+, comorbidities, primary renal disease).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close